StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$7.56+0.04 (+0.53%)

Close on Nov 13, 2026Market cap $661.48MP/E –Yield –

Olema Oncology statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 15, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$661.48M
$272.32M
Enterprise Value
$247.68M
$146.23M
PB Ratio
1.79
2.00
P/TBV Ratio
1.79
2.22

Share statisticsIndustry

Shares Change (YoY)
20.4%
10.8%
Shares Change (QoQ)
0.10%
0.50%
Float
48M
49M
Shares Held by Insiders
45.7%
11.7%
Shares Held by Institutions
116.5%
56.4%

Short sellingIndustry

Short Interest
17M
–
Short Interest Change
9.22%
-0.80%
Short % of Float
36.0%
9.01%
Short % of Shares Outstanding
19.6%
6.30%
Days to Cover
11.86
5.15

Stock price statisticsIndustry

52-Week High
$36.26
–
52-Week Low
$6.24
–
20-Day Moving Average
$7.21
–
50-Day Moving Average
$8.18
–
200-Day Moving Average
$13.08
–
Average True Range (14)
$0.58
–
Price Change (1 Week)
3.14%
-1.15%
Price Change (1 Month)
10.0%
-4.87%
Price Change (3 Months)
-29.8%
-21.0%
Price Change (6 Months)
-44.4%
-20.6%
Price Change (YTD)
-69.8%
-23.6%
Price Change (1 Year)
-6.20%
-22.4%
Price Change (3 Years)
-52.4%
-29.5%
Price Change (5 Years)
-72.0%
-77.9%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
1M
–
Relative Volume
1.46
0.70
Relative Strength Index (14)
50.2
43.4
Volatility (1 Year)
154.2%
80.1%
Beta (5 Years)
1.64
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-69.8%
-49.9%
Return on Assets (ROA)
-59.5%
-40.6%
Return on Capital Employed (ROCE)
-68.0%
-37.9%

Financial positionIndustry

Current Ratio
6.12
3.30
Quick Ratio
5.98
2.39

EfficiencyIndustry

Profits Per Employee
-$1.80M
-$689.41K
Employee Count
131
74
WACC
13.3%
10.2%

Income statement (TTM)Industry

Operating Income
-$252.77M
-$21.37M
Net Income
-$235.95M
-$22.35M
EBITDA
-$252.27M
-$17.21M
EPS (Diluted)
-$2.36
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$413.80M
$17.76M
Net Cash Per Share
$4.73
$0.80
Equity (Book Value)
$368.84M
$53.89M
Book Value Per Share
$4.22
$1.50
Tangible Book Value
$368.84M
$27.13M
Working Capital
$354.19M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$177.32M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-35.7%
-21.8%

Scores and fair valueIndustry

Altman Z-Score
2.07
0.23
Piotroski F-Score
3
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodOLMAS&P 500DifferenceOLMA per yearS&P 500 per year
1 month+7.7%-3.0%+10.7 pts
3 months-28.1%-2.8%−25.3 pts
Year to date-69.8%+11.5%−81.2 pts
1 year-4.8%+13.5%−18.2 pts
3 years-48.7%+77.7%−126.4 pts-20.0%+21.1%
5 years-72.0%+72.6%−144.6 pts-22.5%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

17M OLMA shares were sold short on Oct 30, 2026, up 9.2% from the previous report, or 36.05% of the shares available to trade. At recent volumes it would take 11.9 days to buy them back. Over the last 20 sessions, 59.9% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202617,124,622+9.2%1,443,36811.9
Oct 15, 202615,678,877+6.7%1,172,11013.4
Sep 30, 202614,696,219-8.5%1,441,96010.2
Sep 15, 202616,068,469+2.6%1,008,45215.9
Aug 31, 202615,663,548-0.9%845,05218.5
Aug 14, 202615,808,921-1.0%1,109,53414.3
Jul 31, 202615,963,215+5.7%876,85418.2
Jul 15, 202615,101,848+7.6%1,337,32711.3
Jun 30, 202614,033,964+9.3%2,471,4055.7
Jun 15, 202612,843,113+7.7%1,630,8017.9
May 29, 202611,927,602+2.9%1,133,21810.5
May 15, 202611,587,581-11.1%1,131,25710.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?